Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT01446159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2 Randomized Study of MEDI-573 in Combination With an Aromatase Inhibitor (AI) Versus AI Alone in Women With Metastatic Breast Cancer (MBC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study to evaluate the safety, tolerability, antitumor activity, and pharmacology of MEDI-573 in combination with an aromatase inhibitor (AI) in adult subjects with HR+, HER2-negative MBC.
Study identification
- NCT ID
- NCT01446159
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 188 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 13, 2011 (Actual)
- Primary completion
- Jun 28, 2019 (Actual)
- Completion
- Jun 28, 2019 (Actual)
- Last update posted
- Jun 2, 2020
2011 – 2019
United States locations
- U.S. sites
- 34
- U.S. states
- 15
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Scottsdale | Arizona | 85259 | — |
| Research Site | Bakersfield | California | 93309 | — |
| Research Site | Pleasant Hill | California | 94523 | — |
| Research Site | Stamford | Connecticut | 06904 | — |
| Research Site | Fort Myers | Florida | 33901 | — |
| Research Site | Orlando | Florida | 32804 | — |
| Research Site | Port Saint Lucie | Florida | 34952-7596 | — |
| Research Site | St. Petersburg | Florida | 33705 | — |
| Research Site | Athens | Georgia | 30607 | — |
| Research Site | Augusta | Georgia | 30901 | — |
| Research Site | Lawrenceville | Georgia | 30046 | — |
| Research Site | Scarborough | Maine | 04074 | — |
| Research Site | Baltimore | Maryland | 21224 | — |
| Research Site | Baltimore | Maryland | 21231 | — |
| Research Site | Bethesda | Maryland | 20817 | — |
| Research Site | Frederick | Maryland | 21701 | — |
| Research Site | Rockville | Maryland | 20850 | — |
| Research Site | Ann Arbor | Michigan | 48106-0995 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | Rochester | Minnesota | 55904 | — |
| Research Site | Albuquerque | New Mexico | 87131 | — |
| Research Site | Lake Success | New York | 11041 | — |
| Research Site | Lake Success | New York | 11042 | — |
| Research Site | Canton | Ohio | 44718 | — |
| Research Site | Cincinnati | Ohio | 45267 | — |
| Research Site | Cleveland | Ohio | 44106 | — |
| Research Site | Cleveland | Ohio | 44195 | — |
| Research Site | Middletown | Ohio | 45042 | — |
| Research Site | Toledo | Ohio | 43608 | — |
| Research Site | Memphis | Tennessee | 38120 | — |
| Research Site | Nashville | Tennessee | 37205 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Lubbock | Texas | 79410 | — |
| Research Site | Richmond | Virginia | 23230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01446159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2020 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01446159 live on ClinicalTrials.gov.